ArticleHaematologica2011

The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11).

Bartosz Wasag et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.